These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
222 related articles for article (PubMed ID: 32058261)
21. Very-High-Dose Prednisolone Before ACTH for Treatment of Infantile Spasms: Evaluation of a Standardized Protocol. Eliyan Y; Heesch J; Alayari A; Rajaraman RR; Sankar R; Hussain SA Pediatr Neurol; 2019 Oct; 99():16-22. PubMed ID: 31331669 [TBL] [Abstract][Full Text] [Related]
22. Safety and effectiveness of hormonal treatment versus hormonal treatment with vigabatrin for infantile spasms (ICISS): a randomised, multicentre, open-label trial. O'Callaghan FJ; Edwards SW; Alber FD; Hancock E; Johnson AL; Kennedy CR; Likeman M; Lux AL; Mackay M; Mallick AA; Newton RW; Nolan M; Pressler R; Rating D; Schmitt B; Verity CM; Osborne JP; Lancet Neurol; 2017 Jan; 16(1):33-42. PubMed ID: 27838190 [TBL] [Abstract][Full Text] [Related]
23. Vigabatrin as First-Line Treatment for Infantile Spasms Not Related to Tuberous Sclerosis Complex. Jones K; Go C; Boyd J; Ochi A; McCoy B; Puka K; Snead OC Pediatr Neurol; 2015 Aug; 53(2):141-5. PubMed ID: 26227562 [TBL] [Abstract][Full Text] [Related]
24. Limited efficacy of the ketogenic diet in the treatment of highly refractory epileptic spasms. Hussain SA; Shin JH; Shih EJ; Murata KK; Sewak S; Kezele ME; Sankar R; Matsumoto JH Seizure; 2016 Feb; 35():59-64. PubMed ID: 26803052 [TBL] [Abstract][Full Text] [Related]
25. High vigabatrin dosage is associated with lower risk of infantile spasms relapse among children with tuberous sclerosis complex. Hussain SA; Schmid E; Peters JM; Goyal M; Bebin EM; Northrup H; Sahin M; Krueger DA; Wu JY; Epilepsy Res; 2018 Dec; 148():1-7. PubMed ID: 30296632 [TBL] [Abstract][Full Text] [Related]
33. Strength and stability of EEG functional connectivity predict treatment response in infants with epileptic spasms. Shrey DW; Kim McManus O; Rajaraman R; Ombao H; Hussain SA; Lopour BA Clin Neurophysiol; 2018 Oct; 129(10):2137-2148. PubMed ID: 30114662 [TBL] [Abstract][Full Text] [Related]
34. Vigabatrin therapy for infantile spasms: review of major trials in Europe, Canada, and the United States; and recommendations for dosing. Carmant L Acta Neurol Scand Suppl; 2011; (192):36-47. PubMed ID: 22061179 [TBL] [Abstract][Full Text] [Related]
35. Effect of vigabatrin on seizure control and safety profile in different subgroups of children with epilepsy. Jackson MC; Jafarpour S; Klehm J; Thome-Souza S; Coughlin F; Kapur K; Loddenkemper T Epilepsia; 2017 Sep; 58(9):1575-1585. PubMed ID: 28691157 [TBL] [Abstract][Full Text] [Related]
36. Fifteen years of real-world data on the use of vigabatrin in individuals with infantile epileptic spasms syndrome. Kuchenbuch M; Lo Barco T; Chemaly N; Chiron C; Nabbout R Epilepsia; 2024 Feb; 65(2):430-444. PubMed ID: 37872396 [TBL] [Abstract][Full Text] [Related]
37. Clinical features and electroclinical evolution in 22 cases with epileptic spasms without hypsarrhythmia. Koichihara R; Hamano SI; Daida A; Nonoyama H; Ikemoto S; Hirata Y; Matsuura R Epileptic Disord; 2020 Feb; 22(1):73-82. PubMed ID: 32020895 [TBL] [Abstract][Full Text] [Related]
38. The United Kingdom Infantile Spasms Study (UKISS) comparing hormone treatment with vigabatrin on developmental and epilepsy outcomes to age 14 months: a multicentre randomised trial. Lux AL; Edwards SW; Hancock E; Johnson AL; Kennedy CR; Newton RW; O'Callaghan FJ; Verity CM; Osborne JP; Lancet Neurol; 2005 Nov; 4(11):712-7. PubMed ID: 16239177 [TBL] [Abstract][Full Text] [Related]